Published on :
German health authorities announced Tuesday, March 30, that the use of the AstraZeneca vaccine will be restricted to people over the age of 60. A decision taken when several cases of blood clots were noted. Those under the age of 60 who wish to be vaccinated with AstraZeneca will first need to take an exam. </p><div> <p>The AstraZeneca vaccine - which changed its name on Tuesday, March 30 and is now called Vaxzevria, according to the European Medicines Agency - is still talking about it in Germany. At the end of the day, the regional and federal ministries of health communicated on the use of the formula of the Swedish-British pharmaceutical group.
Following a recommendation issued a little earlier by the German Vaccination Commission (STIKO), the health authorities will reserve the use of AstraZeneca vaccine people over 60 years old. According to the media The mirror, the Paul Ehrlich Medical Institute is examining 31 reports of blood clots in people who received the AstraZeneca vaccine. Almost all of these cases involve young or middle-aged women.
Always questions and precautions around the AstraZeneca
The regional and federal ministries of health indicate that people under the age of 60 who wish to receive the AstraZeneca vaccine will be able to do so, but only after ” consultation of a doctor practicing vaccination (…) and a personalized risk analysis “. As for people under the age of 60 who have already received a first dose, they can either receive the second dose or wait for the STIKO recommendation, scheduled for the end of April.
The same STIKO pleads for an AstraZeneca vaccination reserved for over 60s, based on data showing ” the rare but very serious occurrence of thrombosis as a side effect “. A phenomenon that affects ” mainly people under the age of 60, between four and sixteen days after vaccination ».
This same suspicion of thrombosis as a side effect prompted several countries to temporarily discontinue vaccination with AstraZeneca during the month of March. On Monday March 29, Canada announced that this vaccine would be reserved for people over 55, pending further analyzes.
Jens Spahn, the German Minister of Health, told a press conference that this restriction on the AstraZeneca vaccine would not undermine the country’s goal of offering vaccination to all of its population. adult ” by the end of the summer ».
<p><em>(With AFP)</em> </div>
Source site www.rfi.fr